Fresenius Medical Care AG Overview
Research snapshot
Latest filing date 2026-08-27This Mavefund research page organizes verified information for Fresenius Medical Care AG (FME.DE), including the company profile, price history, source-linked filings, available financial statements, research signals, and risks to review.
- Listing
- FME.DE · XETRA · MIC XETR
- Country
- Germany
- Trading currency
- EUR
- Financial coverage
- Annual and interim statements available
- Latest filing source
- SEC EDGAR · filed 2026-08-27
Primary sources
- Latest SEC EDGAR filing Filed 2026-08-27
- Verified listing source
Coverage is refreshed automatically and published only after data-integrity validation. Research support only; not personalized financial advice.
Reported Results
What the company reported, with filing details kept small.
Interim result summary
Exhibit 99.1 Press Release Media contact Christine Peters T +49 160 60 66 770 [email protected] Kirsten Stratton T +1 781 929 8096 [email protected] Contact for analysts and investors Dr. Dominik Heger T +49 617...
What changed
- Review the source filing for the full reported results and management commentary.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the source document to review full management commentary.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.
Other recent earnings materials
SEC filing
FORM 6-K
Aug 27, 2026
SEC filing
FORM 6-K
Aug 03, 2026
Earnings release
EXHIBIT 99.1
Aug 03, 2026
SEC filing
FORM 6-K
Aug 03, 2026
Earnings release
EXHIBIT 99.1
Aug 03, 2026
Earnings release
EXHIBIT 99.2
Aug 03, 2026
Earnings release
EXHIBIT 99.1
Aug 03, 2026
SEC filing
FORM 6-K
Jul 29, 2026
Earnings release
EXHIBIT 99.1
Jul 29, 2026
SEC filing
FORM 6-K
May 28, 2026
Earnings release
EXHIBIT 99.2
May 28, 2026
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
No qualified company news in the last 14 days
No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.
Financial Statements
Company-reported filing facts, organized and linked to the original source.
Verified source-linked statements load when this section enters view.
Source details load with the filing data. Values are standardized company disclosures for research support, not personalized financial advice.